Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan;218(1):130.e1-130.e13.
doi: 10.1016/j.ajog.2017.11.554. Epub 2017 Nov 11.

Mortality and pulmonary outcomes of extremely preterm infants exposed to antenatal corticosteroids

Colm P Travers  1 , Waldemar A Carlo  2 , Scott A McDonald  1 , Abhik Das  1 , Edward F Bell  1 , Namasivayam Ambalavanan  1 , Alan H Jobe  1 , Ronald N Goldberg  1 , Carl T D'Angio  1 , Barbara J Stoll  1 , Seetha Shankaran  1 , Abbot R Laptook  1 , Barbara Schmidt  1 , Michele C Walsh  1 , Pablo J Sánchez  1 , M Bethany Ball  1 , Ellen C Hale  1 , Nancy S Newman  1 , Rosemary D Higgins  1 ; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network
Collaborators, Affiliations

Mortality and pulmonary outcomes of extremely preterm infants exposed to antenatal corticosteroids

Colm P Travers et al. Am J Obstet Gynecol. 2018 Jan.

Abstract

Background: Antenatal corticosteroids are given primarily to induce fetal lung maturation but results from meta-analyses of randomized controlled trials have not shown mortality or pulmonary benefits for extremely preterm infants although these are the infants most at risk of mortality and pulmonary disease.

Objective: We sought to determine if exposure to antenatal corticosteroids is associated with a lower rate of death and pulmonary morbidities by 36 weeks' postmenstrual age.

Study design: Prospectively collected data on 11,022 infants 22 0/7 to 28 6/7 weeks' gestational age with a birthweight of ≥401 g born from Jan. 1, 2006, through Dec. 31, 2014, were analyzed. The rate of death and the rate of physiologic bronchopulmonary dysplasia by 36 weeks' postmenstrual age were analyzed by level of exposure to antenatal corticosteroids using models adjusted for maternal variables, infant variables, center, and epoch.

Results: Infants exposed to any antenatal corticosteroids had a lower rate of death (2193/9670 [22.7%]) compared to infants without exposure (540/1302 [41.5%]) (adjusted relative risk, 0.71; 95% confidence interval, 0.65-0.76; P < .0001). Infants exposed to a partial course of antenatal corticosteroids also had a lower rate of death (654/2520 [26.0%]) compared to infants without exposure (540/1302 [41.5%]); (adjusted relative risk, 0.77; 95% confidence interval, 0.70-0.85; P < .0001). In an analysis by each week of gestation, infants exposed to a complete course of antenatal corticosteroids had lower mortality before discharge compared to infants without exposure at each week from 23-27 weeks' gestation and infants exposed to a partial course of antenatal corticosteroids had lower mortality at 23, 24, and 26 weeks' gestation. Rates of bronchopulmonary dysplasia in survivors did not differ by antenatal corticosteroid exposure. The rate of death due to respiratory distress syndrome, the rate of surfactant use, and the rate of mechanical ventilation were lower in infants exposed to any antenatal corticosteroids compared to infants without exposure.

Conclusion: Among infants 22-28 weeks' gestational age, any or partial antenatal exposure to corticosteroids compared to no exposure is associated with a lower rate of death while the rate of bronchopulmonary dysplasia in survivors did not differ.

Keywords: antenatal corticosteroids; bronchopulmonary dysplasia; infant; intracranial hemorrhage; mechanical ventilation; morbidity; mortality; necrotizing enterocolitis; neonatal; newborn; patent ductus arteriosus; periventricular leukomalacia; pneumothorax; preterm; pulmonary; pulmonary hemorrhage; respiratory distress syndrome; respiratory support; sepsis; surfactant.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Frequency of exposure to antenatal corticosteroids (ANS) by gestational age and year of birth. The administration of antenatal corticosteroids increased over the study period but remained lower at the lower gestational ages.
Figure 2
Figure 2
Death before discharge of infants 22 to 28 weeks’ gestation by antenatal corticosteroid (ANS) exposure. Infants exposed to a course of antenatal corticosteroids had a lower rate of death before discharge compared to infants who were not exposed to antenatal corticosteroids at each gestational age from 23 to 27 weeks. Infants exposed to a partial course of antenatal corticosteroids had lower mortality at 23, 24, and 26 weeks’ gestation.
See this image and copyright information in PMC

References

    1. Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2006;3:CD004454. - PubMed
    1. Onland W, de Laat MW, Mol BW, Offringa M. Effects of antenatal corticosteroids given prior to 26 weeks’ gestation: a systematic review of randomized controlled trials. Am J Perinatol. 2011;28(1):33–44. - PubMed
    1. Carlo WA, McDonald SA, Fanaroff AA, et al. for the NICHD Neonatal Research Network Association of antenatal corticosteroids with mortality and neurodevelopmental outcomes among infants born at 22 to 25 weeks’ gestation. JAMA. 2011;306(21):2348–58. - PMC - PubMed
    1. Wong D, Abdel-Latif M, Kent A, NICUS Network Antenatal steroid exposure and outcomes of very premature infants: a regional cohort study. Arch Dis Child Fetal Neonatal Ed. 2014;99(1):F12–20. - PubMed
    1. Mori R, Kusuda S, Fujimura M, Neonatal Research Network Antenatal corticosteroids promote survival of extremely preterm infants born at 22 to 23 weeks of gestation. J Pediatr. 2011;159(1):110–114. - PubMed

Publication types

MeSH terms

Supplementary concepts

Grants and funding